Erik Holmberg, Onkologiskt centrum, Sahlgrenska Universitetssjukhuset

Basuppgifter

Arbete

CV

Article - Peer reviewed scientific (74)

1. [Mesothelioma of the peritoneum--a neglected diagnosis?]

   Järvholm B, Holmberg E, Näslund P E, Sandén A, Zettergren L.

   Lakartidningen 1984:81(8):644-5.

   [Links: PMID: 6700320][Source: PubMed®]
2. Intracavitary irradiation of carcinoma of the cervix stage IB and IIA. A clinical comparison between a remote high dose-rate afterloading system and a low dose-rate manual system.

   Himmelmann A, Holmberg E, Odén A, Skogsberg K.

   Acta Radiol Oncol 1985:24(2):139-44.

   [Links: PMID: 2988276][Source: PubMed®]
3. The effect of postoperative external radiotherapy on cervical carcinoma stage IB and IIA.

   Himmelmann A, Holmberg E, Jansson I, Odén A, Skogsberg K.

   Gynecol Oncol. 1985:22(1):73-84.

   [Links: PMID: 4018663][Source: PubMed®]
4. Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. The Myeloma Group of Western Sweden.

   Hjorth M, Hellquist L, Holmberg E, Magnusson B, Rödjer S, Westin J.

   Br J Haematol. 1990:74(2):185-91.

   [Links: PMID: 2180471][Source: PubMed®]

   Web of Science® citations 48
5. Relationship between kerma and treatment volume in intracavitary radiation therapy.

   Ragnhult I, Holmberg E, Mattsson S.

   Acta Oncol 1990:29(3):307-12.

   [Links: PMID: 2363943][Source: PubMed®]
6. Association of ploidy and cell proliferation, Dukes' classification, and histopathological differentiation in adenocarcinomas of colon and rectum.

   Wahlström B, Branehög I, Stierner U, Sunzel H, Holmberg E.

   Eur J Surg 1992:158(4):237-42; discussion 2.

   [Links: PMID: 1352139][Source: PubMed®]

   Web of Science® citations 8
7. Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden.

   Hjorth M, Holmberg E, Rödjer S, Westin J.

   Br J Haematol. 1992:80(1):55-61.

   [Links: PMID: 1536810][Source: PubMed®]

   Web of Science® citations 39
8. Energy and macronutrient intake in relation to cancer incidence among Swedish women.

   Lissner L, Helgesson O, Bengtsson C, Lapidus L, Hultén B, Branehög I, Holmberg E.

   Eur J Clin Nutr 1992:46(7):501-7.

   [Links: PMID: 1623854][Source: PubMed®]

   Web of Science® citations 2
9. Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden.

   Hjorth M, Hellquist L, Holmberg E, Magnusson B, Rödjer S, Westin J.

   Eur J Haematol. 1993:50(2):95-102.

   [Links: PMID: 8440364][Source: PubMed®]

   Web of Science® citations 85
10. Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

    Knudsen L M, Hippe E, Hjorth M, Holmberg E, Westin J.

    Eur J Haematol. 1994:53(4):207-12.

    [Links: PMID: 7957804][Source: PubMed®]

    Web of Science® citations 102
11. Cancer incidence after radiotherapy for skin haemangioma during infancy.

    Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lunberg L M, Wallgren A.

    Acta oncologica (Stockholm, Sweden) 1995:34(6):735-40.

    [Links: PMID: 7576739][Source: PubMed®]

    Web of Science® citations 59
12. Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres.

    Hjorth M, Holmberg E, Rödjer S, Taube A, Westin J.

    Br J Haematol. 1995:91(1):109-15.

    [Links: PMID: 7577616][Source: PubMed®]

    Web of Science® citations 11
13. Cancer morbidity in rheumatoid arthritis patients treated with Proresid or parenteral gold.

    Bendix G, Bjelle A, Holmberg E.

    Scand J Rheumatol. 1995:24(2):79-84.

    [Links: PMID: 7747148][Source: PubMed®]

    Web of Science® citations 11
14. Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group.

    No registered authors.

    Ann Intern Med. 1996:124(2):212-22.

    [Links: PMID: 8533996][Source: PubMed®]
15. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study.

    Berg G, Michanek A, Holmberg E, Nyström E.

    J Intern Med. 1996:239(2):165-71.

    [Links: PMID: 8568485][Source: PubMed®]

    Web of Science® citations 27
16. Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group.

    Wisløff F, Eika S, Hippe E, Hjorth M, Holmberg E, Kaasa S, Palva I, Westin J.

    Br J Haematol. 1996:92(3):604-13.

    [Links: PMID: 8616024][Source: PubMed®]

    Web of Science® citations 53
17. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.

    Berg G E, Michanek A M, Holmberg E C, Fink M.

    J Nucl Med. 1996:37(2):228-32.

    [Links: PMID: 8667049][Source: PubMed®]

    Web of Science® citations 62
18. Soft tissue sarcoma after treatment for breast cancer.

    Karlsson P, Holmberg E, Johansson K A, Kindblom L G, Carstensen J, Wallgren A.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996:38(1):25-31.

    [Links: PMID: 8850423][Source: PubMed®]

    Web of Science® citations 44
19. Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myeloma.

    Hjorth M, Holmberg E, Rödjer S, Taube A, Westin J.

    Control Clin Trials 1996:17(5):372-86.

    [Links: PMID: 8932971][Source: PubMed®]

    Web of Science® citations 24
20. Advanced laryngeal cancer T3-T4 in Sweden: a retrospective study 1986-1990. Survival and locoregional control related to treatment.

    Finizia C, Geterud A, Holmberg E, Lindström J, Lundgren J, Kuylenstierna R, Rylander R, Biörklund A, Rydell R, Andréason L, Mercke C.

    Acta Otolaryngol. 1996:116(6):906-12.

    [Links: PMID: 8973731][Source: PubMed®]

    Web of Science® citations 12
21. Prognostic factors for acute and late skin reactions in radiotherapy patients.

    Turesson I, Nyman J, Holmberg E, Odén A.

    Int J Radiat Oncol Biol Phys. 1996:36(5):1065-75.

    [Links: PMID: 8985028][Source: PubMed®]

    Web of Science® citations 131
22. Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study.

    Hultborn R, Gundersen S, Rydén S, Holmberg E, Carstensen J, Wallgren U B, Kilany S.

    Acta Oncol 1996:35:73-4.

    [Links: PMID: 9142971][Source: PubMed®]

    Web of Science® citations 20
23. Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.

    Hultborn R, Johansson-Terje I, Bergh J, Glas U, Hallsten L, Hatschek T, Holmberg E, Ideström K, Norberg B, Ranstam J, Söderberg M, Wallgren U B.

    Acta Oncol 1996:35:75.

    [Links: PMID: 9142972][Source: PubMed®]

    Web of Science® citations 6
24. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study.

    Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson S L.

    J Urol. 1997:157(3):800-3; discussion 80.

    [Links: PMID: 9072570][Source: PubMed®]

    Web of Science® citations 83
25. Intracranial tumors after radium treatment for skin hemangioma during infancy--a cohort and case-control study.

    Karlsson P, Holmberg E, Lundberg L M, Nordborg C, Wallgren A.

    Radiat Res. 1997:148(2):161-7.

    [Links: PMID: 9254735][Source: PubMed®]

    Web of Science® citations 9
26. Survival in a population-based study of conventionally treated younger (< 60 years) myeloma patients - For comparison with patients treated with high dose chemotherapy with stem cell support.

    Hjort M, Holmberg Erik, Rodjer S, Turesson I, Westin J, Wisloff F.

    Blood 1998:92

    [Source: User]
27. Soft tissue sarcoma after treatment for breast cancer--a Swedish population-based study.

    Karlsson P, Holmberg E, Samuelsson A, Johansson K A, Wallgren A.

    Eur J Cancer 1998:34(13):2068-75.

    [Links: PMID: 10070313][Source: PubMed®]

    Web of Science® citations 84
28. Long-term followup of a bladder carcinoma cohort: routine followup urography is not necessary.

    Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson S L.

    J Urol. 1998:160(1):45-8.

    [Links: PMID: 9628602][Source: PubMed®]

    Web of Science® citations 33
29. Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up.

    Landys K, Persson S, Kovarík J, Hultborn R, Holmberg E.

    Breast Cancer Res Treat. 1998:49(1):27-33.

    [Links: PMID: 9694608][Source: PubMed®]

    Web of Science® citations 50
30. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma.

    Karlsson P, Holmberg E, Lundell M, Mattsson A, Holm L E, Wallgren A.

    Radiat Res. 1998:150(3):357-64.

    [Links: PMID: 9728664][Source: PubMed®]

    Web of Science® citations 88
31. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.

    No registered authors.

    J Clin Oncol. 1998:16(12):3832-42.

    [Links: PMID: 9850028][Source: PubMed®]
32. Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG).

    Hjorth M, Holmberg E, Rödjer S, Turesson I, Westin J, Wislöff F.

    Eur J Haematol. 1999:62(4):271-7.

    [Links: PMID: 10227461][Source: PubMed®]

    Web of Science® citations 25
33. Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants.

    Lundell M, Mattsson A, Karlsson P, Holmberg E, Gustafsson A, Holm L E.

    Radiat Res. 1999:151(5):626-32.

    [Links: PMID: 10319736][Source: PubMed®]

    Web of Science® citations 37
34. Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration.

    Dahl I M, Turesson I, Holmberg E, Lilja K.

    Blood 1999:93(12):4144-8.

    [Links: PMID: 10361111][Source: PubMed®]

    Web of Science® citations 23
35. Recurrence and progression in low grade papillary urothelial tumors.

    Holmäng S, Hedelin H, Anderström C, Holmberg E, Busch C, Johansson S L.

    J Urol. 1999:162(3 Pt 1):702-7.

    [Links: PMID: 10458347][Source: PubMed®]

    Web of Science® citations 98
36. Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors.

    Turesson I, Abildgaard N, Ahlgren T, Dahl I, Holmberg E, Hjorth M, Nielsen J L, Odén A, Seidel C, Waage A, Westin J, Wislöff F.

    Br J Haematol. 1999:106(4):1005-12.

    [Links: PMID: 10520004][Source: PubMed®]

    Web of Science® citations 33
37. Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.

    Hultborn R, Gundersen S, Ryden S, Holmberg E, Carstensen J, Wallgren U B, Killany S, Andreassen L, Carlsson G, Fahl N, Hatschek T, Sommer H H, Hessman Y, Hornmark-Stenstam B, Johnsborg S, Klepp R, Laino R, Niklasson L G, Rudenstam C M, Sundbeck A, Söderberg M, Tejler G.

    Anticancer Res. 1999:19(4C):3383-92.

    [Links: PMID: 10629624][Source: PubMed®]

    Web of Science® citations 56
38. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

    Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen J L, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl I M, Gimsing P, Hippe E, Johnsen H, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S.

    Blood 2000:95(1):7-11.

    [Links: PMID: 10607678][Source: PubMed®]

    Web of Science® citations 203
39. Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period.

    Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson S L.

    Scand J Urol Nephrol. 2000:34(2):95-101.

    [Links: PMID: 10903069][Source: PubMed®]

    Web of Science® citations 12
40. Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy.

    Holmberg E, Holm L E, Lundell M, Mattsson A, Wallgren A, Karlsson P.

    Br J Cancer 2001:85(3):362-6.

    [Links: PMID: 11487266 | DOI länk][Source: PubMed®]

    Web of Science® citations 17
41. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.

    Preston Dale L, Mattsson Anders, Holmberg Erik, Shore Roy, Hildreth Nancy G, Boice John D.

    Radiat Res. 2002:158(2):220-35.

    [Links: PMID: 12105993][Source: PubMed®]

    Web of Science® citations 192
42. Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy.

    Holmberg Erik, Wallgren Arne, Holm Lars-Erik, Lundell Marie, Karlsson Per.

    Radiat Res. 2002:158(4):418-23.

    [Links: PMID: 12236809][Source: PubMed®]

    Web of Science® citations 11
43. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.

    Malmström P, Holmberg L, Anderson H, Mattsson J, Jönsson P E, Tennvall-Nittby L, Balldin G, Lovén L, Svensson J H, Ingvar C, Möller T, Holmberg E, Wallgren A.

    Eur J Cancer 2003:39(12):1690-7.

    [Links: PMID: 12888363][Source: PubMed®]

    Web of Science® citations 56
44. Cancer and oral lichen planus in a Swedish population.

    Rödström Per-Olof, Jontell Mats, Mattsson Ulf, Holmberg Erik.

    Oral Oncol. 2004:40(2):131-8.

    [Links: PMID: 14693235][Source: PubMed®]

    Web of Science® citations 41
45. The incidence and survival of acute de novo leukaemias in Estonia and in a well-defined region of western Sweden during 1982-1996: a survey of patients aged > or =65 years.

    Luik E, Palk K, Everaus H, Varik M, Aareleid T, Wennström L, Juntikka E-L, Safai-Kutti S, Stockelberg D, Holmberg E, Kutti J.

    J Intern Med. 2004:256(1):79-85.

    [Links: PMID: 15189369 | DOI länk][Source: PubMed®]

    Web of Science® citations 3
46. The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of Western Sweden during 1982-1996: a survey of patients aged 16-64 years.

    Wennström Lovisa, Juntikka Eva-Lena, Safai-Kutti Soodabeh, Stockelberg Dick, Holmberg Erik, Luik Ene, Everaus Hele, Palk Katrin, Varik Mirja, Aareleid Tiiu, Kutti Jack.

    Leuk Lymphoma 2004:45(5):915-21.

    [Links: PMID: 15291349][Source: PubMed®]

    Web of Science® citations 5
47. The impact of reproductive factors on breast cancer risk--the feasibility of using Swedish population-based registers to account for the effect of confounding in cohort studies.

    Holmberg Erik, Anderson Harald, Lundell Marie, Karlsson Per.

    Cancer Causes Control 2005:16(3):235-43.

    [Links: PMID: 15947875 | DOI länk][Source: PubMed®]

    Web of Science® citations 5
48. Improved survival with clinical guidelines? Evaluation of a quality register linked to clinical guidelines for ovarian cancer in the western health care region in Sweden between 1 September 1993 and 1 June 1998

    Akeson Margaretha, Zetterqvist Britt-Marie, Holmberg Erik, Horvath György.

    Acta Obstet Gynecol Scand 2005:84(11):1113-8.

    [Links: PMID: 16232182 | DOI länk][Source: PubMed®]

    Web of Science® citations 9
49. Intensive therapy in newly diagnosed multiple myeloma patients below 60 years. A prospective, controlled, population based study.

    Lenhoff S, Turesson I, Hjort M, Holmberg Erik, Westin J.

    Blood 2006:108

    [Source: User]

    Web of Science® citations 0
50. Dexamethasone and cyclophosphamide: More convenient and as effective as VAD before high-dose melphalan and autologous transplantation in newly diagnosed multiple myeloma. Results of a randomized NMSG trial.

    Mellqvist UH, Lenhoff S, Hjort M, Holmberg Erik, Juliusson G, Tangen JM, Westin J, Johnsen H.

    Blood 2006:108

    [Source: User]

    Web of Science® citations 0
51. Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.

    Juliusson G, Billström R, Gruber A, Hellström-Lindberg E, Höglunds M, Karlsson K, Stockelberg D, Wahlin A, Aström M, Arnesson C, Brunell-Abrahamsson U, Carstensen J, Fredriksson E, Holmberg E, Nordenskjöld K, Wiklund F;
    Swedish Adult Acute Leukemia Registry Group.

    Leukemia 2006:20(1):42-7.

    [Links: PMID: 16327841 | DOI länk][Source: PubMed®]

    Web of Science® citations 23
52. Leukemia in the vicinity of an oil refinery.

    Barregard L, Sallsten G, Holmberg Erik.

    Epidemiology 2007:18

    [Source: User]
53. Analysis of survival differences over time and between countries in three trials within the nordic myeloma study group. Impact of international clinical collaboration on treatment and outcome.

    Johnsen HE, Hjort M, Lenhoff S, Roer O, Klausen TW, Holmberg Erik, Gisselo CG, Nielsen JL, Storm HH, Waage A, Wisloff F, Giemsing P, Westin J.

    Haematology Journal 2007:92:208-9.

    [Source: User]

    Web of Science® citations 0
54. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.

    Adolfsson Jan, Garmo Hans, Varenhorst Eberhard, Ahlgren Göran, Ahlstrand Christer, Andrén Ove, Bill-Axelson Anna, Bratt Ola, Damber Jan-Erik, Hellström Karin, Hellström Magnus, Holmberg Erik, Holmberg Lars, Hugosson Jonas, Johansson Jan-Erik, Petterson Bill, Törnblom Magnus, Widmark Anders, Stattin Pär.

    Scand J Urol Nephrol. 2007:41(6):456-77.

    [Links: PMID: 17934985 | DOI länk][Source: PubMed®]

    Web of Science® citations 45
55. Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer Registry.

    Holmäng Sten, Amsler-Nordin Susanne, Carlson Kerstin, Holmberg Erik, Johansson Sonny L.

    Scand J Urol Nephrol. 2008:42(1):12-7.

    [Links: PMID: 17853011 | DOI länk][Source: PubMed®]

    Web of Science® citations 3
56. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.

    Mellqvist Ulf-Henrik, Lenhoff Stig, Johnsen Hans E, Hjorth Martin, Holmberg Erik, Juliusson Gunnar, Tangen Jon Magnus, Westin Jan;
    Nordic Myeloma Study Group.

    Cancer 2008:112(1):129-35.

    [Links: PMID: 17973267 | DOI länk][Source: PubMed®]

    Web of Science® citations 11
57. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden.

    Stattin Pär, Holmberg Erik, Bratt Ola, Adolfsson Jan, Johansson Jan-Erik, Hugosson Jonas.

    J Urol. 2008:180(6):2423-9; discussion 2.

    [Links: PMID: 18930283 | DOI länk][Source: PubMed®]

    Web of Science® citations 17
58. Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiotherapy - a randomized study.

    Lundstedt D, Gustafsson M, Malmström P, Olofsson U, Holmberg Erik, Andersson H, Steineck G, Karlsson P.

    Breast 2009:18:46-7.

    [Source: User]
59. A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors.

    Akeson Margaretha, Jakobsen Anne-Marie, Zetterqvist Britt-Marie, Holmberg Erik, Brännström Mats, Horvath György.

    Int J Gynecol Cancer 2009:19(1):116-23.

    [Links: PMID: 19258952 | DOI länk][Source: PubMed®]

    Web of Science® citations 3
60. Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden.

    Carlsson Sigrid, Adolfsson Jan, Bratt Ola, Johansson Jan-Erik, Ahlstrand Christer, Holmberg Erik, Stattin Par, Hugosson Jonas.

    Scand J Urol Nephrol. 2009:1-7.

    [Links: PMID: 19396725 | DOI länk][Source: PubMed®]
61. Breast cancer risk among Swedish hemangioma patients and possible consequences of radiation-induced genomic instability.

    Eidemüller Markus, Holmberg Erik, Jacob Peter, Lundell Marie, Karlsson Per.

    Mutat Res. 2009

    [Links: PMID: 19416732 | DOI länk][Source: PubMed®]

    Web of Science® citations 6
62. Leukaemia incidence in people living close to an oil refinery.

    Barregard Lars, Holmberg Erik, Sallsten Gerd.

    Environ Res. 2009:109(8):985-90.

    [Links: PMID: 19781695 | DOI länk][Source: PubMed®]
63. Regional Differences in Local Recurrence Rates after Rectal Cancer Surgery.

    Kodeda K, Holmberg E, Steineck G, Nordgren S.

    Colorectal Dis 2009

    [Links: PMID: 19912284 | DOI länk][Source: PubMed®]
64. Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden.

    Carlsson Sigrid, Adolfsson Jan, Bratt Ola, Johansson Jan-Erik, Ahlstrand Christer, Holmberg Erik, Stattin Pär, Hugosson Jonas.

    Scand J Urol Nephrol. 2009:43(5):350-6.

    [Links: PMID: 19921978 | DOI länk][Source: PubMed®]

    Web of Science® citations 4
65. The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged >or=65 years.

    Palk Katrin, Luik Ene, Varik Mirja, Viigimaa Iige, Vaht Krista, Everaus Hele, Wennström Lovisa, Stockelberg Dick, Safai-Kutti Soodabeh, Holmberg Erik, Kutti Jack.

    Cancer Epidemiol 2010:34(1):24-8.

    [Links: PMID: 20071253 | DOI länk][Source: PubMed®]

    Web of Science® citations 1
66. Variation in position and volume of organs at risk in the small pelvis.

    Waldenström Ann-Charlotte, Alsadius David, Pettersson Niclas, Johansson Karl-Axel, Holmberg Erik, Steineck Gunnar, Müller Markus.

    Acta Oncol 2010:49(4):491-9.

    [Links: PMID: 20397776 | DOI länk][Source: PubMed®]

    Web of Science® citations 3
67. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.

    Stattin Pär, Holmberg Erik, Johansson Jan-Erik, Holmberg Lars, Adolfsson Jan, Hugosson Jonas;
    National Prostate Cancer Register (NPCR) of Sweden.

    J Natl Cancer Inst. 2010:102(13):950-8.

    [Links: PMID: 20562373 | DOI länk][Source: PubMed®]

    Web of Science® citations 27
68. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

    Hugosson Jonas, Carlsson Sigrid, Aus Gunnar, Bergdahl Svante, Khatami Ali, Lodding Pär, Pihl Carl-Gustaf, Stranne Johan, Holmberg Erik, Lilja Hans.

    Lancet Oncol. 2010:11(8):725-32.

    [Links: PMID: 20598634 | DOI länk][Source: PubMed®]
69. Cancer incidence in a petrochemical industry area in Sweden.

    Axelsson Gösta, Barregard Lars, Holmberg Erik, Sallsten Gerd.

    Sci Total Environ. 2010:408(20):4482-7.

    [Links: PMID: 20619881 | DOI länk][Source: PubMed®]
70. Rectal washout and local recurrence of cancer after anterior resection.

    Kodeda K, Holmberg E, Jörgren F, Nordgren S, Lindmark G.

    Br J Surg 2010:97(10):1589-97.

    [Links: PMID: 20672364 | DOI länk][Source: PubMed®]

    Web of Science® citations 0
71. Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Followup Study.

    Holmström Benny, Holmberg Erik, Egevad Lars, Adolfsson Jan, Johansson Jan-Erik, Hugosson Jonas, Stattin Pär;
    on behalf of the National Prostate Cancer Register of Sweden.

    The Journal of urology 2010

    [Links: PMID: 20723940 | DOI länk][Source: PubMed®]
72. No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer.

    Carlsson Sigrid V, Holmberg Erik, Moss Sue M, Roobol Monique J, Schröder Fritz H, Tammela Teuvo L J, Aus Gunnar, Auvinen Anssi P, Hugosson Jonas.

    BJU international 2010

    [Links: PMID: 20950305 | DOI länk][Source: PubMed®]
73. Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial.

    Lundstedt Dan, Gustafsson Magnus, Malmström Per, Johansson Karl-Axel, Alsadius David, Sundberg Agnetha, Wilderäng Ulrica, Holmberg Erik, Anderson Harald, Steineck Gunnar, Karlsson Per.

    Radiother Oncol 2010:97(2):281-7.

    [Links: PMID: 20970212 | DOI länk][Source: PubMed®]

    Web of Science® citations 3
74. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite-A phase II study from the Swedish Lung Cancer Study Group.

    Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers S-B, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J.

    Lung Cancer 2011:71(2):166-72.

    [Links: PMID: 20541833 | DOI länk][Source: PubMed®]

    Web of Science® citations 4

• Civilingenjör, Teknisk Fysk, Chalmers Tekniska Högskola 1975
• Radiofysik 60 poäng, Göteborgs Universitet 1980
• Disputerad 12 november 2004. Methodological Aspects on Excess Cancer Risk after Exposure to Ionising Radiation

| uppdaterad: 2011-01-27 av Erik Holmberg |